Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed
This article was originally published in The Gray Sheet
Executive Summary
TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004